Carcinoma: all 6,719 studies
Page 57 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.CompletedNCT01469429Phase 1/2
- Effect of Probiotics in Patients Undergoing Surgery for Periampullary NeoplasmsCompletedNCT01468779Phase 3
- Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell CarcinomaStatus unknownNCT01467921Phase 2
- Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human SkinTerminatedNCT01466504
- Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)WithdrawnNCT01465815Phase 1/2
- Freeze-Dried Black Raspberries in Treating Patients With Oral Squamous Cell Cancer Undergoing SurgeryCompletedNCT01465776Not applicable
- A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid TumorsStatus unknownNCT01462903Phase 1
- L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic MetastasesCompletedNCT01462513Phase 2
- Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal CarcinomaCompletedNCT01462474Phase 1
- Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial CarcinomaCompletedNCT01460979Phase 2
- Radiotherapy & Olaparib in COmbination for Carcinoma of the OesophagusStatus unknownNCT01460888Phase 1
- An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary HyperparathyroidismCompletedNCT01460030Phase 3
- Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT01459380Phase 1
- Resource-Sparing Curative Treatment for Rectal CancerStatus unknownNCT01459328Phase 3
- Study of Postoperative 3D-CRT/IMRT in Hepatocellular CarcinomaCompletedNCT01456156Not applicable
- A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial CarcinomaCompletedNCT01455493Phase 2
- A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or CarcinosarcomaStatus unknownNCT01454479Phase 1
- Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic TargetsCompletedNCT01454180Phase 2
- A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)Status unknownNCT01451658Phase 4
- Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal CarcinomaCompletedNCT01449942Phase 1/2
- PF-00299804 in Patients With Head and Neck Squamous Cell CarcinomaCompletedNCT01449201Phase 2
- Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)CompletedNCT01447667Not applicable
- Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199WithdrawnNCT01445275
- Evaluate the Efficacy of Sorafenib in Renal Cell Carcinoma Patients After a Radical Resection of the MetastasesStatus unknownNCT01444807Phase 2
- A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal CarcinomatosisCompletedNCT01443260Phase 1/2
- Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted TherapyCompletedNCT01442090Phase 2
- Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell CarcinomaCompletedNCT01441661
- Transient Elastography in Hepatectomy for Hepatocellular CarcinomaStatus unknownNCT01441453Not applicable
- A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.WithdrawnNCT01441388Phase 1
- -02341066 and PF-00299804 for Advanced Non-Small Cell Lung CancerTerminatedNCT01441128Phase 1
- Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial CancerCompletedNCT01440998Phase 1
- Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular CarcinomaStatus unknownNCT01438450Phase 2/3
- Trial of Ablation of Small Hepatocellular Carcinomas in Patients of CirrhosisStatus unknownNCT01438437Phase 4
- Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder CancerTerminatedNCT01438112Phase 2/3
- DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or SiblingsCompletedNCT01434355
- Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab OnlyCompletedNCT01434303Phase 1
- Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)WithdrawnNCT01432314Phase 2
- Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT01429961Phase 2
- Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and NeckCompletedNCT01427478Phase 3
- Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)WithdrawnNCT01427205Phase 2
- A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular CarcinomaTerminatedNCT01425996Phase 1/2
- Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell CarcinomaCompletedNCT01425736Phase 2
- Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals PatientsCompletedNCT01424878
- SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity TreatmentTerminatedNCT01418742Phase 2
- NHS-IL12 for Solid TumorsCompletedNCT01417546Phase 1
- BRAF V600E Mutations In Papillary Thyroid CarcinomaStatus unknownNCT01417442Early Phase 1
- Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01417390Phase 2
- Dovitinib in Adenoid Cystic CarcinomaCompletedNCT01417143Phase 2
- Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC PatientsCompletedNCT01415674Phase 2
- Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular CarcinomaStatus unknownNCT01415063Phase 4
- Amatuximab for High Mesothelin CancersTerminatedNCT01413451Early Phase 1
- Nexavar Post-marketing Surveillance for RCC in Japan: Early Access ProgramCompletedNCT01412671
- Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in JapanCompletedNCT01411436
- Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in JapanCompletedNCT01411423
- Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT01409499Phase 4
- Sorafenib in First-line Treatment of Advanced B Child Hepatocellular CarcinomaTerminatedNCT01405573Phase 3
- Association Between Hepatitis C Infection and Renal Cell CarcinomaCompletedNCT01405183
- Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell CarcinomaCompletedNCT01404104Not applicable
- Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisionsCompletedNCT01403480
- SOX as Salvage Treatment in Nasopharyngeal CarcinomaTerminatedNCT01403259Phase 2
- Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After EsophagectomyStatus unknownNCT01402180Phase 2/3
- Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0Status unknownNCT01398449Phase 3
- Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.CompletedNCT01398306
- Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder CancerCompletedNCT01395225
- Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT01392235Phase 2
- Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC)Status unknownNCT01392131Phase 1/2
- A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal CancerStatus unknownNCT01391572Phase 2
- Search for Predictors of Therapeutic Response in Ovarian CarcinomaCompletedNCT01391351Not applicable
- Safety Study of MGA271 in Refractory CancerCompletedNCT01391143Phase 1
- Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular CarcinomaCompletedNCT01390194
- Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through DownstagingCompletedNCT01387503Not applicable
- Resection for Multiple Hepatocellular Carcinomas (HCC)CompletedNCT01387061Not applicable
- Feasibility of VMAT and CBCT for Head and Neck CarcinomasCompletedNCT01384890Phase 1
- Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal CancerCompletedNCT01383343Phase 1
- Nimotuzumab With Radiotherapy in the Treatment of Anal Canal CancersTerminatedNCT01382745Phase 2
- Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine TumorsStatus unknownNCT01381822Phase 1
- Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS)CompletedNCT01381614
- Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)CompletedNCT01381601
- Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC)TerminatedNCT01381211Phase 2
- Feasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial CarcinomasTerminatedNCT01380795Early Phase 1
- The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular CarcinomaStatus unknownNCT01380392
- Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric CancerCompletedNCT01379482Phase 2
- Cabazitaxel - PF Induction ChemotherapyCompletedNCT01379339Phase 1
- DNA Methylation and Urothelial CarcinomaStatus unknownNCT01378052
- Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT01377298Phase 2
- Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular CarcinomaStatus unknownNCT01377220Phase 2
- Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)CompletedNCT01374750Phase 2
- Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid CarcinomaStatus unknownNCT01374659
- Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for RectumcarcinomaCompletedNCT01372007Phase 3
- Clinical Diagnosis of Basal Cell Carcinoma SubtypeCompletedNCT01370824
- MK-2206 in Recurrent Nasopharyngeal CarcinomaCompletedNCT01370070Phase 2
- New Approach of Assessing Drug Response for Treatment of Nasopharyngeal CancerCompletedNCT01365208
- Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical CancerTerminatedNCT01363466Phase 3
- Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive TractStatus unknownNCT01361100Not applicable
- AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the LiverCompletedNCT01361061
- EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01360827Phase 1
- DNA Methylation and Arsenic-associated Urothelial CarcinomaStatus unknownNCT01360723
- AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)CompletedNCT01360255
- Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to TherapyCompletedNCT01358097
- Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell CarcinomaCompletedNCT01358045Phase 2